Amydis has received $2.5 million to continue mapping toxic deposits of TDP-43 in retinal tissue and develop an eye test for ALS.
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results